Targeting tumor supporting cells: Lipid nanoparticles advance CAR T success in pancreatic cancer

Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...
The Lancet

Expanding the ADT-free therapeutic landscape in oligometastatic hormone-sensitive prostate cancer

The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...